Logo

People in the News: Fahim Amini, Sheli Rosenberg, Michael McGarrity, Andre de Bruin, and Others

Jun 04, 2013
Premium

BioNano Genomics has appointed Fahim Amini to serve as its new vice president of commercial operations for Europe, the Middle East, and Africa. In the role, he will be responsible for selling the company's Irys System into the EMEA markets.

Amini recently was director of EMEA at Complete Genomics, and before that, he played similar roles at Illumina and Affymetrix.

Nanosphere's shareholders have re-elected five members of its board of directors to continue serving until the next shareholder meeting in 2014, including: Sheli Rosenberg; Michael McGarrity; André de Bruin; Lorin Randall; and Michael Ward.

Filed under

Microarrays & Multiplexing
Bionano Genomics
microarrays
Luminex
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.